The 6th DDR Inhibitors Summit is taking place in-person for the first time in 3 years in Boston, MA this January 24 – 26, 2023.

The DNA damage response inhibitor space only continues to grow, with progress being accelerated by a shift in focus onto next-generation targets like PolQ and WRN, moving forward from monotherapies through combining targets and exploiting sensitivity caused by DDRis to enhance other therapies like radiotherapy.

The scope of this year’s meeting is to bring together leading minds in DDRi drug development to exploring these strategies and aim to address issues related to emerging DDR inhibitor resistance and maximizing efficacy, as well as addressing the biggest challenge in the space right now, toxicity.

The 3-day meeting will consist of a comprehensive overview of the DDR space, with over 30+ world class speakers sharing insights preclinical updates, progress in the clinic, solutions to overcoming toxicity and improving patient selection.

Don’t miss out on hearing from the best in the field on how to overcome toxicity and resistance during drug design as well as in the clinic, to maximize efficacy and propel your DDR inhibitors to success.

To know more visit: https://ter.li/40qr50